Clinical Trials Directory

Trials / Terminated

TerminatedNCT04449328

Induced Motion Illusions Through Vision and Tendon Vibrations: Study of Interactions in Hemiplegic Subjects

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
33 (actual)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

Two movement illusion techniques can currently be used in clinical practice for motor rehabilitation after stroke hemiplegia: visual illusion (mirror therapy) and proprioceptive illusion (tendon vibration). Mirror therapy, in its computerized version (IVS3, Dessintey, Saint-Etienne, France), is based on the substitution of the deficient visual feedback by a visual feedback of a correctly realized movement. The proprioceptive illusion is based on the external application of a vibrator on muscle tendons at a frequency between 50 and 120 Hz. These two techniques are currently used independently. They are, in theory, complementary and additive. No study has described the combinatorial properties of the illusions generated by these 2 techniques in hemiplegic subjects and healthy subjects.

Detailed description

The study hypothesis is that the administration of mirror therapy together with vibration will increase the perception of movement in a subjective scale.

Conditions

Interventions

TypeNameDescription
DEVICEComputerized Mirror Therapy (CMT)Computerized Mirror Therapy (CMT) will be realizing by the device Intensive Visual Simulation 3 (IVS3). The patient looks on a screen in front of him, mirroring the movements made by his hand, while attempting to perform the same movement with his other hand.
DEVICETendon vibrationTranscutaneous vibrations are used. This device allows vibrations from 50 to 120 Hz with amplitude of 1 mm. This study the frequency used is 70 and 80 Hz.

Timeline

Start date
2021-04-30
Primary completion
2023-04-25
Completion
2023-04-28
First posted
2020-06-26
Last updated
2023-05-30

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04449328. Inclusion in this directory is not an endorsement.